Evidence map›Paper›PMID 36172186›Full record

ReviewFrontiers in pharmacology2022

Meng Lu, Xintian Lan, Xi Wu, Xiaoxue Fang, Yegang Zhang, Haoming Luo, Wenyi Gao, Donglu Wu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Meng LuSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Xintian LanSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Xi WuSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Xiaoxue FangSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Yegang ZhangSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Haoming LuoSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Wenyi GaoSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Donglu WuKey Laboratory of Effective Components of Traditional Chinese Medicine, Changchun, China.
Changchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are small non-coding RNAs that play important roles in gene regulation by influencing the translation and longevity of various target mRNAs and the expression of various target genes as well as by modifying histones and DNA methylation of promoter sites. Consequently, when dysregulated, microRNAs are involved in the development and progression of a variety of diseases, including cancer, by affecting cell growth, proliferation, differentiation, migration, and apoptosis. Preparations from the dried root and rhizome of

Indexed as

apoptosiscancercombination medicationhistone modificationsmicroRNASalvia miltiorrhiza

Identifiers

PMID36172186
PMCPMC9512245
OpenAlexW4297872391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.